The FAQs are grouped into categories of related topics for your convenience:
– Click the category title to get to the associated FAQs
The FAQs are grouped into categories of related topics for your convenience:
– Click the category title to get to the associated FAQs
In case your question is not answered here, feel free to contact us directly through e-mail (contact@navinci.se) or by filling in the enquiry form on the support page.
Proximity Ligation Assay or Proximity Ligation Technology is a technology for localized protein detection. When pairs of Navenibodies bind protein targets in close proximity, their conjugated oligonucleotides can template circularization of an added pair of oligonucleotides via enzymatic ligation. The circularized DNA strands remain hybridized to the Navenibodies, and one of the oligonucleotides serves as a primer for a localized rolling circle amplification (RCA) reaction. The resulting amplified DNA is detected as a bright fluorescent or chromogenic dot by suitably labeled detection probes. Read more about the technology and the inventors here.
The UnFold technique differs from the traditional PLA technique in that all DNA elements required for amplified detection are included in the oligonucleotides conjugated to the antibodies. The technique is a patented design used as the base for Naveni® product development. Read more about the technique here.
A Navenibody is an antibody conjugated to an oligonucleotide sequence, also known as a “proximity probe”. When two Navenibodies are in close proximity, the oligonucleotides can template circularization of an added pair of oligonucleotides, starting a rolling circle amplification (RCA) reaction leading to a strong and distinct dot. Read more about the technology here.
The quality of the staining obtained with the primary antibodies depends on the type of fixative used. The ideal fixative preserves cellular and tissue morphology while rapidly arresting degradative processes such as autolysis, by crosslinking and inhibiting endogenous enzymes. If no particular fixation procedure is recommended for your antibody, then the optimal fixation protocol must be determined for the primary antibody and assay; this may vary depending on the type of cell or tissue as well as your protein of interest. Naveni products is compatible with all fixatives typically used for IHC/IF, including:
Please refer to the appropriate literature or your primary antibody provider for more specific details.
If your antibodies call for different fixation conditions, you may need to prioritize which antibody to use at its optimal requirements. Performing a small-scale test comparing different conditions may be informative before scaling up your experiments.
Two major antigen retrieval methods are generally used on formalin-fixed paraffin-embedded (FFPE) tissue sections: Heat-Induced Epitope Retrieval (HIER) and Proteolytic-Induced Epitope Retrieval (PIER). Both methods are compatible with all naveni products. For HIER it may be necessary to optimize the pH of your solution.
Example of buffers and enzymes used for antigen retrieval:
Permeabilization of cellular membranes allows large molecules such as antibodies, oligonucleotides, and enzymes to enter the cell, providing access to intracellular epitopes. It is crucial to optimize the type of permeabilizing agent as well as the exposure time for each experiment.
It is important to include experimental controls when running any experiment, including NaveniFlex/Bright, for the results to be properly evaluated. Both negative and positive controls should be included, and these can be either biological or technical.
As a positive control, use two antibodies that recognize two proteins known to interact in the cells or tissues of interest. Alternatively, two antibodies that recognize different epitopes of the same protein may be used, if available.
The Naveni® in situ proximity ligation technology products offers the possibility to visualize the subcellular location of proteins, protein interactions, and protein modifications, provided that the two targeted epitopes are within 40 nm of each other.
The reaction volume should be adjusted to the sample area. For a reaction area of ca 1 cm2 (typical for grown cells mounted on a chamber slide), a reaction volume of 40 µL is suitable. Ensure that the entire sample is covered with the staining solution.
Reaction volume guidelines
If the slides are mounted correctly, they can be stored at +4°C (in the dark) without the risk of losing any of the signal. However, we recommend imaging the slides within a few days of the experiment.
Yes, you can use cells grown on plastic slides.
Naveni® products are optimized for use in human tissue samples. They may be compatible with tissues from other species, but Navinci Diagnostics cannot guarantee successful staining.
No. Naveni® technology has been developed and optimized for use in fixed cells and tissues.
No adjustments are necessary; Navinci’s BOND RX kits come pre-optmized for immediate application on both BOND RX and RXm instruments. However, when introducing a new antibody pair with the universal kit, there may be a need to calibrate the antibody binding step.
The reagents are bench-top stable for at least 24 hours at room temperature, allowing overnight runs.
A full run including baking and dewax as well as antigen retrieval takes around 9 hours.
Antigen retrieval and dewax need to be optimized for each primary antibody pair and tissue type for best use. The standard BOND *dewax program and antigen retrieval buffer ER2, used at 100°C for 40min works for most tissues and proteins (*HIER 40 min). If this condition is too harsh, the time can be shortened or a change to ER1 antigen retrieval buffer can be done. When setting up a new in situ Proximity Ligation assay, it is recommended to optimize the dewax and antigen retrieval for each antibody pair with IHC (BOND polymer refine) before starting the interaction assay.
BOND Polymer Refine Detection, or BOND Intense R Detection System and a titration kit is needed to be able to run any protocol on the BOND. Other detection kits from Leica Biosystems containing hematoxylin and peroxide block can also be used. It is also possible to use Streptavidin-HRP and DAB from the Bond Intense R detection kit from Leica.
It is recommended to use technical protocols where one and/or both primary antibodies is/are omitted or using a tissue with a known positive and/or negative expression of the proteins. FFPE cells with various levels of expression of one or the other protein could also be used as a control. Below is an example of controls that were used during validation. Other examples of controls are to exchange one of the primary antibodies with an isotype control, or to use antibodies for an interaction that should not be present.
MR – One mouse and one rabbit primary antibody are present in the isPLA reaction. Each one targets one of the respective interaction partners, resulting in isPLA signals in a tissue positive for the assayed interaction, single protein or PTM.
M – Only the mouse primary antibody is present in the isPLA reaction, resulting in no signal, independent of tissue and the presence or absence of the targeted protein(s).
R – Only the rabbit primary antibody is present in the isPLA reaction, resulting in no signal, independent of tissue and the presence or absence of the targeted protein(s).
B – No primary antibodies are present in the isPLA reaction, resulting in no signal, independent of tissue.
Bio NC – One mouse and one rabbit primary antibody are present in the isPLA reaction in a tissue negative for the interaction (biological negative control), resulting in no signal.
The reagents are always prepared in one tube, even if it is single or double dispensed. The kit contains sufficient reagent volumes in all steps where double dispensing is needed.
A starting concentration of 1-2 μg/ml primary antibody is recommended, but titration might be needed for each separate antibody. We recommend testing the antibodies using IHC with concentrations recommended by the vendor before applying them for isPLA to verify that they are functional. Final titration of primary antibodies should always be performed in the proximity ligation assay.
When setting up a new antibody pair on the BOND RX or RXm, the in situ Proximity Ligation Assay signal is sometimes much lower than expected or not detected even after functional testing with IHC. One reason could be that the proteins are not in proximity. Another reason could be that the epitope which one of the antibodies should bind to is blocked when the interaction happens. Further, the titer of primary antibodies could be too imbalanced. The table below presents an example of antibody optimization in the BOND. A high concentration could be in the range of 2-5 µg/ml, and a low concentration could be in the range of 0,1-1 µg/ml.
Experimental setup example:
Mouse primary antibody concentration | Rabbit primary antibody concentration | |
---|---|---|
Condition 1 | Low concentration | Low concentration |
Condition 2 | High concentration | High concentration |
Condition 3 | Low concentration | High concentration |
Condition 4 | High concentration | Low concentration |
Other suggestions for optimization are to test the in situ proximity ligation assay at ambient temperature vs 37°C, different incubation times and double dispensing of the primary antibodies.
Edge effect and artefact staining tend to increase when the concentration of the primary antibodies is too high, generating unspecific staining. The first thing to do when there is background is to titrate the antibodies, and secondly run a less harsh antigen retrieval.
Edge effects on the tissue could also be due to tissue processing. If the tissue is placed too close to the covertile edges, or is very large, artefacts can increase. Other sources of edge effects could be old covertiles and insufficient cleaning of the BOND RX/RXm probe.
The volume of each solution described in the tables of the protocol includes a dead volume.
Make sure that each slide is scanned correctly. If some protocols are not properly loaded, you can manually set the protocol for an individual slide. This is done by marking the slide which has not been assigned a protocol and then double-click on the protocol which is to be loaded to the protocol. The software will do a short analysis of the experiment to see if all the reagents needed for the loaded slides are in place and that there is enough volume for all reagents. If everything is approved by the instrument the run can be started. In that case the “start button” will be available and no warning icons are shown.
In case the user is using additional antibodies they will have to add titration containers assigned as marker type of the different antibodies in the software and then scan them into the protocol used.
Refer to the Leica BOND RX manual which has recommendations of tissue size and position on the glass slide, or contact Navinci customer support for advice.
Any brightfield microscope can be used to visualize the in situ Proximity Ligation Assay staining.
AP is not available.
The kit has been validated for up to 3 freeze/thaw cycles.
Yes.
Please contact Leica Biosystems service and support.
Please contact Leica Biosystems service and support.
No programming is needed for running the Naveni protocols. If you want to add additional stainings, you will have to add container names of the different antibodies in the software and then scan them into the protocol used.
We recommend using VectaMount Express mounting from Vector labs since it contains a clearing
reagent. If any other mounting medium is used, refer to the guideline for that mounting medium. Other mounting mediums that have been used are Faramount Aqueous Mounting medium (DAKO) and Pertex mounting medium.
Yes, some small changes are needed for optimal performance.
Protein target binding specificity may differ depending on the buffers used for blocking and antibody dilution. The NaveniFlex Cell blocking and antibody/probe diluents , provided in the kit, are compatible with most antibodies. The blocking and diluent composition differs from the original NaveniFlex and the antibody performance should be re-verified with immunofluorescent staining before proceeding with NaveniFlex Cell experiments.
If the NaveniFlex Cell blocking solution results in significantly reduced signal strength or increased background for a particular antibody, please contact us at contact@navinci.se for advice.
Due to NaveniFlex Cells´ increased sensitivity, the primary antibody concentration should be titrated to determine the optimal dilution for each antibody that gives rise to the highest number of separated signals while keeping the background to a minimum.
Start with the antibody concentration from your previous NaveniFlex experiments. Perform the antibody titration on both positive and negative controls.
To ensure success, antibodies must be carefully selected and parameters including sample fixation, antigen retrieval, blocking, and antibody dilution must be optimized before running a NaveniFlex or NaveniBright assay to ensure optimal antibody binding.
The primary antibodies should be of IgG class, specific for your protein target and preferably affinity purified. They can be either polyclonal or monoclonal antibodies. Always validate the antibody by IF/IHC before carrying out a NaveniFlex or NaveniBright assay.
Tips for choosing antibodies:
Antibody species:
The species of your antibodies should be appropriate for the selected NaveniFlex or NaveniBright kit:
The primary antibody concentration is an essential determinant for any immunoassay. It should be titrated to determine the optimal dilution for each antibody that gives rise to the highest number of separated signals while keeping background to a minimum.
Start with the antibody concentration from your previous IF or IHC experiments (if applicable), or the concentration recommended in the antibody datasheet. Perform the antibody titration on both positive and negative controls.
Detection and quantification of interacting proteins can be accomplished using a different primary antibody for each of the two interacting proteins. The antibodies should be from two different species.
Detection and quantification of a protein and its putative posttranslational modification can be done using two different primary antibodies, one directed against the target protein and one against a modification site on the same protein. For phosphorylation studies, for example, you could use a pan-Tyr antibody that recognizes a broad range of tyrosine phosphorylation sites.
To detect one protein with the same high level of specificity obtained from a dual recognition assay, two primary antibodies directed against the same protein are required. The two antibodies must be able to recognize their epitopes within the same experimental settings.
We recommend NaveniFlex Tissue GR for mouse tissue experiment. When mouse antibodies are used on mouse cells or tissue in an immunoassay, this often results in high background signal.
In many cases, background can be reduced by performing an extra blocking step with unconjugated anti-mouse secondary antibodies (preferably Donkey Anti-Mouse) for 1 hour at room temperature. Ensure that the final antibody concentration is not lower than 0.1 mg/mL. Increasing the blocking time to 2 hours at room temperature or overnight at 4 ºC can be more effective for some assays. In this case, a lower concentration of antibody may be applied. Perform the additional blocking step after the ordinary blocking step and ensure that the samples are washed before and after.
Our secondary antibodies are raised in donkey.
No, it is not possible to detect protein interactions, modifications, or homodimers using two antibodies from the same species.
No, this is not currently possible. The kits allow you to detect only one protein-protein interaction per assay.
Yes. The Naveni® products, with fluorescent readout, have speck-like signals, and each speck can be counted as separate object as long as the proteins of interest are not overly abundant. We recommend quantification by measuring the intensity per cell in each separate channel, or by object segmentation of the speck-like signal and counting. The number of cells can be accounted for by identifying the number of cell nuclei, so do not forget to include a nuclear stain as recommended in the kit instructions.
It is possible, but there are no quick fixes that will work on all protein-RNA interactions. We recommend using an oligo sequence complementary to the RNA, tagged with a hapten (e.g. biotin), and then adding a mouse/rabbit/goat anti-biotin antibody. You would then be able to detect anti-biotin antibodies in proximity to the protein-specific antibody.
At the moment our kits are only compatible with primary antibodies raised in mouse, rabbit, or goat. However, since sheep and goats are closely related species, the Navenibodies against goat primary antibodies may display some cross-reactivity with sheep antibodies. If your primary antibody works with anti-goat secondary antibodies in an immunofluorescence assay, it should also work with our kit. However, this must be tested for each particular antibody.
At the moment our kits can only be used with primary antibodies raised in mouse, rabbit, or goat. However, since rats and mice are closely related, the Navenibodies against mouse primary antibodies may cross-react with the rat antibodies to some degree. If your primary antibody works with anti-mouse secondary antibodies in an immunofluorescence assay, it should also work with our kit. However, this must be tested for each particular antibody.
The Naveni® products are not optimized for use on whole-mount tissues. If you want to stain whole mounts, then the protocol will need to be adjusted. We recommend prolonging each incubation by 50%. An increased enzyme concentration may also be needed.
Protein target binding specificity may differ depending on the buffers used for blocking and antibody dilution. The NaveniFlex Cell blocking and antibody/probe solutions, provided in the kit, are optimized for NaveniFlex Cell assays and are compatible with most antibodies. However, antibody performance should be verified with immunofluorescent staining before proceeding to NaveniFlex Cell experiments.
If the NaveniFlex Cell blocking solution results in significantly reduced signal strength or increased background for a particular antibody, check the product datasheet for recommendations regarding applicable blocking and antibody diluents.
We recommend Fluoroshield mounting medium (Sigma, F6182). Most mounting mediums compatible with IHC/IF will also work for Naveni® products.
The NaveniFlex Control kit has been designed as a control for the NaveniFlex Cell MR proximity ligation assay and to help the user distinguish between positive and negative signals. The Control kit contains two primary antibodies against HER2 (raised in mouse and rabbit) and three slides with fixed, pretreated, and dehydrated BT474 cells, and is ready for use with the NaveniFlex MR Cell protocol
We recommend using “the number of signals observed per field of view/cell” for reporting Naveni data. If your signals have coalesced and you cannot quantify them separately, try reducing the exposure time during imaging. Imaging software can often identify intensity maxima in an image even though they are too weak to be discerned by the naked eye.
Signal intensity should not be used as a measurable parameter.
The Naveni® in situ proximity ligation assay generates distinct, round signals of around 500 nm diameter, which are best visualized using at least a 20X objective (sometimes a 40X may be needed).
With NaveniFlex Cell you can detect protein interactions, analyze endogenous proteins, and study protein modification with the possibility of relative quantification on fixed cells. All NaveniFlex Cell products are based on a secondary antibody system that enables a highly sensitive and specific readout of the selected target(s). You should select which kit to use according to your primary antibody species and preferred filter set for signal detection.
There are two ways to co-immunostain with NaveniFlex Cell. Either use a primary antibody directly conjugated to a fluorophore or a primary antibody against your co-stain target together with a secondary antibody conjugated to a fluorophore. If you use the second approach, make sure that the primary antibody targeted by your secondary antibody is not from the same species as the two primary antibodies used for the NaveniFlex Cell assay.
Co-immunostaining should be performed after Reaction 2 (step 6) but before nuclear staining (step 7). Use your internal protocol for the optimal incubation time.
The NaveniFlex Cell kit consists of two boxes shipped separately. Upon receipt, store Box 1 at 4-8 °C and Box 2 at -15 to -25 °C. When stored as directed, the product is stable for at least six months after receipt. All reagents in Box 2 should be stored at -20 °C. This is especially critical for enzymes, which should also be kept on ice when removed from the freezer. The probes, antibodies, probe diluents, and blocking solution should be stored at +4 °C.
Yes. The NaveniFlex Cell assay generates dot-like signals, and each dot can be counted as a separate object as long as the proteins of interest are not overly abundant. We recommend quantification by either measuring the intensity per cell in each separate channel or by object segmentation of the dot-like signal and object counting. The number of cells can be accounted for by identifying the number of cell nuclei, so remember to include a nuclear stain as recommended in the kit instructions.
NaveniFlex Cell can be applied to all sample types that can be used for in situ staining with traditional staining methods such as immunofluorescence (IF) and immunohistochemistry (IHC). The samples should be immobilized on slides or cell culture plates, fixed and permeabilized.
No, the NaveniFlex Cell can only be used on fixed cells.
Yes, it is possible, although the NaveniFlex Cell products are optimized and specifically designed for cell-based assays. To perform experiments on tissue, we strongly recommend the NaveniFlex Tissue products. The NaveniFlex Tissue products are designed for tissues, improving sensitivity and removing cell-type specific bbackgrounds seen in many tissue samples.
All NaveniFlex Cell batches are thoroughly quality-controlled and tested with various antibodies on human cell lines to ensure high quality and reproducibility. New batches are always compared against older batches to ensure lot-to-lot consistency.
NaveniFlex Tissue is specifically designed for tissues, where it improves sensitivity and removes high background seen in certain samples. In these problematic tissues, NaveniFlex Tissue is your best choice to obtain the optimal number of signals and image clarity. If you work with cells, NaveniFlex is the kit for you.
The workflow and reagents are optimized to give more sensitive detection in tissue samples. Our proprietary blocking procedures ensure significantly lower backgrounds.
Yes, NaveniFlex Tissue can be used on fresh frozen human and mouse tissues.
Yes, NaveniFlex Tissue can be used on fresh frozen human and mouse tissues.
Yes, it is possible, although we recommend that you use NaveniFlex for cell samples.
You can choose the NaveniFlex Tissue kit according to your preferred filter set on your fluorescent microscope. Choose between NaveniFlex Tissue RED, with fluorescent dye for the Cy3.5 filter set (Abs max: 595 nm, Exc max: 627), and NaveniFlex Tissue Atto647N, with fluorescent dye for the Cy 5 filter set (Abs max: 649 nm; Exc max 662 nm).
NaveniFlex Tissue is validated on FFPE and fresh frozen human and mouse tissue sections. The product is validated on several types of tissue, both healthy and cancerous e.g., colon, tonsil, ovary, kidney, breast, spleen, brain, skin.
No, only the unspecific background generated by specific cell types within the tissue is blocked. For most tissues, autofluorescence is much lower in intensity than the proximity ligation signals, making them easy to detect. If you have a problem with autofluorescence, we recommend you choose the NaveniFlex Tissue kit with the Atto647N detection fluorophore. If the problem persists, autofluorescence can be identified in the FITC channel and subtracted.
All batches of NaveniFlex Tissue are thoroughly quality controlled and tested with various antibodies on human FFPE tissue samples to ensure high quality and reproducibility. New batches are always compared against older batches to ensure lot-to-lot consistency.
There are two ways to co-stain with NaveniFlex tissue. Either with a primary antibody directly conjugated to a fluorophore or by using a secondary antibody conjugated to a fluorophore. If you use the second approach you must make sure that the primary antibody targeted by your secondary antibody is not from the same species as the two primary antibodies used for the NaveniFlex Tissue assay.
Follow the provided kit instructions from step 8.4 for the final steps of the protocol.
The Naveni® TriFlex Cell MR reagents have a working volume of 4000µl (sufficient for approx. 100 reactions).
Naveni® TriFlex Cell MR is a flexible product and allows you to select your preferred primary antibodies, as long as one of them is raised in mouse, and the other one in rabbit. Everything else is included in the kit.
Unlike our NaveniFlex and NaveniBright product lines, which are exclusively used to study protein interactions or post-translational modifications, Naveni® TriFlex Cell simultaneously detects total protein A, total protein B, and the interaction AB between the two proteins, and thereby makes it possible to study the functional states and interplay of proteins.
Naveni® TriFlex Cell is a novel proximity-based technology that can concurrently visualize two proteins in a free and complex state in any cell compartment, thus opening the door to studying their functional states and interplay in response to stimulation/inhibition, cell division, etc.
Just like our other products, Naveni® TriFlex Cell MR detects an interaction whenever the targeted epitopes A and B are no more than 40 nm apart. This proximity signal is visualized by the Cy5 filter set. However, in addition to complexes, Naveni® TriFlex Cell MR detects each protein of interest individually, regardless of whether it partakes in the interaction or not. This allows you to also visualize the total amount of protein A, targeted by your rabbit primary antibody, with the FITC filter set, as well as the total amount of protein B, targeted by your mouse primary antibody, with the Cy3 filter set.
Naveni® TriFlex Cell relies on two user-determined primary antibodies against the targets of interest, and on proprietary TriFlex Navenibodies (antibody-based proximity reagents). Only proteins located at less than 40 nm distance are recorded as interacting. Naveni® TriFlex detects total protein A, total protein B, and the AB interaction. The detected A, B, and AB signals are amplified and generate fluorescent readout in three channels corresponding to each protein pool. Learn more here
Naveni® TriFlex Cell MR has an unparalleled quick and user-friendly workflow. The total run time depends on your preferred duration of primary antibody incubation, which can vary from 1h at +37˚C up to overnight at +4˚C (recommended). If using the recommended overnight incubation of primary antibodies, the protocol on day one is 1h and on day two the run time is under 4h. If you opt for a 1h at +37˚C primary antibody incubation, the entire assay can be performed in one day with a run time of approximately 6h.
Naveni® TriFlex Cell is a proximity-based kit for the specific and sensitive detection of total protein A and protein B, and their interaction AB.
Yes! However, if your counterstain requires you to use a primary and a fluorescently labeled secondary antibody, the primary antibody needs to be raised in a species different from mouse or rabbit. It can be added after reaction 2. Note that if you are using a fluorophore-conjugated primary antibody, the species of origin does not matter. However, bear in mind that the fluorescent label, be it on a primary or a secondary antibody, needs to have an emission spectrum different from FITC, Cy3, or Cy5, as these are the wavelengths in which Naveni® TriFlex Cell signals A, B and AB will be visible.
No, Naveni® TriFlex Cell cannot be used together with NaveniFlex or similar products.
The kit includes three different dyes, one for each type of signal that Naveni® TriFlex Cell detects. To visualize the rabbit antibody signal, use a filter set with excitation wavelength in the range of 480-490 nm and emission wavelength in the range of 525-535 nm. To visualize the mouse antibody signal, use a filter set with excitation in the range of 545-555 nm and emission wavelength of 575 -585 nm. To visualize the proximity signal, use a filter set excitation wavelength in the range of 635-645 nm and emission wavelength of 665-675 nm.
We suggest that you start by using the lowest recommended concentration for IF by your primary antibody vendor. If further optimization is necessary, the antibodies can conveniently be titrated simultaneously using Naveni® TriFlex Cell MR until you get a good signal-to-noise ratio.
Check out our webshop for an updated price in your currency.
We at Navinci are dedicated to making products that work well with most microscopes. One of the advantages of Naveni™TriFlex Cell is the fact that it allows you to identify true colocalization independent of microscope resolution. To use the kit, you need a minimum of three filter sets: FITC (excitation 480-490 nm, emission 525-535 nm), Cy3 (excitation 545-55 nm, emission 575 -585 nm), and Cy5 (excitation 635-645 nm, emission 665-675 nm). In addition, using a nuclear stain such as DAPI or Hoechst is recommended.
The signal detected with the FITC filter corresponds to total protein A – the protein target of your rabbit primary antibody. The signal detected with the Cy3 filter corresponds to total protein B – the protein target of your mouse primary antibody. The signal detected with the Cy5 filter corresponds to the interaction between protein A and protein B.
All reagents needed to perform the assay are included in the kit, except the mounting medium (VectaMount® Express Mounting Medium (H-5700-60) from Vector Laboratories) and quenching agent (Hydrogen peroxide for NaveniBright HRP and Levamisole for NaveniBright AP).
Tissues and cells may contain endogenous peroxidases or alkaline phosphatase, which can lead to non-specific background staining without proper pretreatment.
Ensure that you are using the appropriate quenching agent for your application
Always follow the vendor protocol when you are quenching your slides. Insufficient quenching could result in non-specific background signal.
No, reagents from the NaveniBright kit should not be mixed or combined with reagents from any other Naveni® products.
We don’t recommended using any buffers or diluents other than those provided in the kit. The NaveniBright blocking and antibody/probe dilution buffers are optimized for use in NaveniBright experiments and are compatible with most antibodies.
Yes, NaveniBright kits are designed to be compatible with other substrates. Any substrate compatible with HRP can be used with the NaveniBright HRP kit, and any substrate compatible with AP can be used with the NaveniBright AP kit. Substrate incubation time must be optimized for each assay.
The NaveniBright kit has been validated on
It is highly likely that the kit can be used on any sample types that are compatible with regular IHC.
Yes, signals developed with AP substrate (NaveniBright AP) will also be visible with a fluorescence microscope. The staining will not be as specific though, as fluorochromes are generally visible over a wide range of fluorescent wavelengths. For nuclear stains or other co-staining, we recommend using fluorophores visible in the Far Red spectra.
The VectaMount® Express Mounting Medium (H-5700-60) from Vector Laboratories is required for optimal staining performance. The VectaMount® Express Mounting Medium (H-5700-60) shortens the dehydration and clearing step as well as retaining the staining. Longer dehydration steps in ethanol can reduce staining intensity.
You may take into consideration what type of tissue you are studying when choosing NaveniBright kit.
Select NaveniBrightfield AP
Select Navenibrightfield HRP
Yes, the recommended way to perform a co-staining is by using an HRP-labelled primary antibody together with the NaveniBright AP kit.
To obtain the best quality images, we recommend using a brightfield microscope with at least a 20X objective. Ensure you select the correct focal plane so that the signals are in focus. It is important to keep all microscope settings constant throughout an experiment.
White balancing:
When you are imaging in Brightfield, the light that hits the sample is sometimes “warmer” or “colder”. This can cause objects in the image to appear more orange or blue than they actually are. Not all cameras automatically adjust for this. White balancing enables you to define a region of the image background as white, which calibrates the camera to see the true colors in the image.
After imaging, slides should be stored at room temperature.
The optimal developing time for the substrates included in the NaveniBright kits can vary and should be decided by the investigator of each assay. It is important to keep the developing time the same for all slides in any comparison study to avoid the risk of drawing false conclusions.
Note: Extensive development time will result in unspecific background shade covering the tissue.
The NaveniBright kits consists of two boxes and two bags, shipped separately: Box 1, Bag 1.2 and Bag 1.3 are shipped at 4-8 °C and Box 2 is frozen on dry ice. Upon receipt, store Box 1 at 4-8 °C and Box 2 at -15 to -25 °C.
NaveniBright HRP
Box 1 | Bag 1.2 | Bag 1.3 | Bag 2 |
Blocking buffer
|
HRP Reagent
|
HRP diluent
|
NaveniBright Buffer 1 (5x)
|
Antibody diluent
|
HRP Substrate 1
|
Nuclear Stain
|
NaveniBright Enzyme 1 (40x)
|
Probe diluent
|
HRP Substrate 2
|
NaveniBright Buffer 2 (5x)
|
|
Supplement 1
|
HRP Substrate 3
|
NaveniBright Enzyme 2 (40x)
|
|
Supplement 2
|
HRP Substrate 4
|
||
Probe M
|
|||
Probe R
|
NaveniBright AP
Box 1 | Bag 1.2 | Bag 1.3 | Bag 2 |
Blocking buffer
|
AP Reagent
|
AP Diluent
|
NaveniBright Buffer 1 (5x)
|
Antibody diluent
|
AP Substrate Diluent
|
Nuclear Stain
|
NaveniBright Enzyme 1 (40x)
|
Probe diluent
|
AP Substrate 1
|
NaveniBright Buffer 2 (5x)
|
|
Supplement 1
|
AP Substrate 2
|
NaveniBright Enzyme 2 (40x)
|
|
Supplement 2
|
|||
Probe M
|
|||
Probe R
|
NaveniLink is a complementary product to the NaveniFlex Cell, NaveniFlex Tissue and NaveniBright kits, which adds extra flexibility by allowing the user to create their own primary or secondary Navenibodies. NaveniLink enables the simple and rapid conjugation of oligonucleotide arms to two antibodies of your choice, independently of host species.
For any new conjugate, initial storage at 4°C is recommended. A preservative may be desirable for long-term storage. Other storage conditions (e.g. frozen at -70°C or at -20°C with 50% glycerol) may also be satisfactory. The best conditions for any new conjugate must be determined by experimentation or by recommendations from the manufacturer. You should also take into account of how the conjugate will be used and avoid adding substances that will need to be removed later, resulting in inevitable loss of conjugate.
Yes, it is possible to combine a custom-conjugated antibody with one Navenibody from the NaveniFlex Cell/Tissue or NaveniBright kits, as long as there is no species cross-reactivity.
The dilution of your custom-made Navenibody will vary depending on the primary antibody and the application. We recommend that you start with an earlier optimized concentration (via IHC or IF). If you get too low signals or experience a technical background, you may need to do a titration.
If you have custom-conjugated a primary antibody: Add the conjugate(s) in Step 3: Primary antibody incubation and follow the instructions from the kit. We recommend overnight incubation at 4°C. If both primary antibodies are conjugated, skip Step 4: Navenibody Incubation, and proceed directly to Step 5: Reaction 1.
If you have custom-conjugated a secondary antibody: Add the conjugate(s) in Step 4: Navenibody incubation and follow the instructions from the kit.
The two Navenibodies bind two individual cytoplasmic epitopes on the RTK, with one Navenibody targeting the protein close to the C-terminal and the other targeting the phosphorylated tyrosine. Navenibodies in close proximity will give rise to an amplified signal, creating a specific and sensitive detection method for phosphorylated RTK’s.
It depends on which phosphorylated protein you are interested in. The Naveni® PTM kits target specific phosphorylated proteins (EGFR, HER2, MET, or PDGFR-beta), and the primary antibodies are included in the kits.
If you are interested in a different phosphorylated protein, we recommend using one of our NaveniFlex kits. NaveniFlex kits allow you to detect phosphorylation of any protein, provided that primary antibodies raised in mouse, rabbit, goat, or a combination of these, are available for your target protein (antibodies not included in kit).
No. The Navenibody which binds to the phosphorylated part of the receptor is a pan tyrosine antibody with a high affinity for a broad range of phosphorylated tyrosine residues. The dual recognition approach of Naveni® PTM, utilizing a generic pan antibody with a receptor-specific antibody, produces highly specific staining.
We don’t recommend using non-human cell lines or tissues with the Naveni® PTM kits. The antibodies included in the kits do not cross-react with species other than human.
The kits have been developed for use on fixed cells. Any cells that are typically used in other immunostaining methods such as IHC or IF can be used in a Naveni® PTM assay.
In addition to the Naveni® PTM detection kit, you will need fixed and pre-treated cells, nuclear staining reagent (DAPI), and traditional immunostaining equipment.
Naveni® PTM kits consist of two boxes that are shipped separately: Box 1 is shipped at 4-8 °C and Box 2 is shipped on dry ice. Upon receipt, store Box 1 at 4-8 °C and Box 2 at –15 to -25 °C.
Box 1 | Box 2 |
Blocking buffer (1x)
|
Buffer A (5x)
|
Probe Diluent (1x)
|
Enzyme A (40x)
|
Primary Navenibody 1 (40x)
|
Buffer B (5x)
|
Primary Navenibody 2 (40x)
|
Enzyme B (40x)
|
Buffer C Atto 488 (5x) (Available on request)
|
|
Buffer C TEX615 (5x)
|
|
Buffer C (Atto 647N (5x) (Available on request)
|
|
Enzyme C (40x)
|
When stored as directed, the product is stable for at least three months after receipt. All reagents in Box 2 should be stored at -20 °C; this is especially critical for the enzymes, which should also be kept on ice when removed from the freezer. The probes, antibody and probe diluents, and blocking solutions should be stored at 4 °C.
The Naveni® CD8/MHC-I kit or assay enables you to visualize the interaction between CD8 and MHC-I in tissues with intact morphology.
Naveni® CD8/MHCI can be used with FFPE tissue material.
The CD8 antibody binds to the intracellular part of the protein and the MHC-I primary antibody binds to the extracellular structures of the protein.
As a positive control for Naveni® CD8/MHC-I assay, we recommend staining human tonsil or Hodgkin’s lymphoma tissues. Negative technical controls are preferably set up by omitting each primary antibody one-by-one, and by omitting both primary antibodies.
No, at present the CD8/MHC-I is only available with fluorescent Atto647N read out. Fluorescent RED read out is available upon request.
Yes, an optimized protocol for the best performance of Naveni® CD8/MHC–I assay is available. Please see the protocol here (PDF).
The Naveni® CD8/MHC-I is only optimized for the detection of the CD8/MHC-I interaction in human tissue.
Yes, the following reagents are required but not provided:
We recommend a heat induced epitope retrieval to perform the Naveni® CD8/MHC-I assay, using a Tris-EDTA buffer at pH 8.5 and your standard antigen retrieval method.
Recommended protocol in short:
The Naveni® CD8/MHC-I assay has been validated in tonsil, liver cancer and Hodgkins’ lymphoma FFPE human tissue sections.
The QC of all batches of the Naveni® CD8/MHC-I kits is carried out on human tonsil FFPE tissue samples. Lot-to-lot consistency is ensured by comparing the QC data of new batches with those of previous ones, including the use of negative technical controls to maintain high-quality standards.
Naveni® CD8/MHC-I has a fluorescence read-out, and any type of fluorescence microscope can be used. Ensure you have access to the Cy5 filter (excitation 635-645 nm, emission 665-675 nm). It is recommended to use a nuclear stain such as DAPI or Hoechst.
Fluorescently labelled primary antibodies may be added together with the detection working solution if co-staining is desired. Follow the provided kit instructions from step 8.2 to perform the co-staining. Please see the protocol here (PDF).
The Naveni® PD1/PD-L1 enables you to visualize the interaction between receptor PD1 and its ligand PD-L1 in tissues with intact morphology.
Naveni® PD1/PD-L1 can be used with fresh frozen and FFPE tissue material use.
Yes, the kit’s performance is verified in a series of human tissues. See a list and example pictures here.
Naveni® PD1/PD-L1 is tested but not validated for fresh frozen material use.
No, the Naveni® PD1/PD-L1 is not optimized for the detection of the PD1/PD-L1 interaction on mouse tissue.
One Navenibody binds extracellular PD1 and the other binds the C-terminus on PD-L1.
Naveni® PD1/PD-L1 is available with either AP or HRP substrate. If you want to co-stain your assay with directly HRP labeled antibodies select Naveni® PD1/PD-L1 AP and if you want to co-stain with directly AP labeled antibodies select Naveni® PD1/PD-L1 HRP.
Yes, the Naveni® PD1/PD-L1 protocol is already optimized for the best performance. Please see the protocol here.
Yes, the following reagents are required but not supplied:
No, we have not observed any need for glycosylation when running Naveni® PD1/PD-L1. There is no steric hindrance keeping the antibodies from binding.
No, we do not recommend digital quantification of the Naveni® PD1/PD-L1 signals. Make sure to include adequate controls in each experiment to be able to get the most out of your Naveni® PD1/PD-L1 results.
Naveni® PD1/PD-L1 has a chromogenic read-out, and any type of bright-field light microscope can be used.
We recommend a pH 6 citrate antigen retrieval buffer for Naveni® PD1/PD-L1 experiments.
Protocol in short:
Using normal tissue adjacent to the tumor is recommended as biological negative control for the PD1/PD–L1 staining in cancer samples. As a positive control, we recommend human tonsil or Hodgkin’s lymphoma tissue.
The Naveni® PD1/PD-L1 Atto647N enables you to fluorescently visualize the interaction between receptor PD1 and its ligand PD-L1 in tissues while keeping their morphology intact. In contrast to detecting the expression of either protein alone, with this kit you can detect the actual activation of this immune checkpoint axis.
Naveni® PD1/PD-L1 Atto647N can be used both with fresh frozen and FFPE tissue.
The primary antibodies in the kit are against PD1 (clone EH33, Cell Signaling Technologies) and PD-L1 (clone SP142, Abcam RabMAb®). They were chosen after careful screening and validation and are included at an optimal concentration to ensure robust and reliable results for each staining you perform.
The PD1 primary antibody binds the extracellular part of the receptor and the PD-L1 antibody binds the C-terminus of the ligand.
Yes, the Naveni® PD1/PD-L1 Atto647N protocol is already optimized for the best performance. Please follow the protocol as described here to ensure that you get reliable data.
An antibody’s ability to react with the antigen may be lowered by fixation, particularly when a tissue is fixed with formalin, which introduces protein cross-linking. This requires a restoration process called antigen retrieval. Please note that we recommend using a Tris EDTA pH 9 antigen retrieval buffer for Naveni® PD1/PD-L1 Atto647N experiments, as we have found it to lead to optimal staining.
The procedure in short:
Yes, additional IF co-staining can easily be incorporated into the protocol. Just add fluorescently labeled antibodies for co-staining at the detection step (Step8) in the kit instructions. Consider the excitation and emission spectra of the additional fluorophores to avoid spectral bleed-through (we suggest FITC or Cy3). It is not recommended to use fluorescently labeled secondary antibodies for co-staining with the Naveni® PD1/PD–L1 Atto647N kit.
Yes! After imaging, please remove the coverslip, wash off the mounting medium, and start your normal H&E protocol.
Yes, the kit’s performance is verified in a series of human tissues. See a list and example images here.
To visualize Naveni® PD1/PD-L1 Atto647N signals, use any epifluorescence microscope with a Cy5 filter set (Abs max: 649 nm; Exc max 662 nm) or a confocal microscope.
Using normal tissue adjacent to the tumor is recommended as biological negative control for the PD1/PD–L1 staining in cancer samples. As a positive control, we recommend human tonsil or Hodgkin’s lymphoma tissue.
You can find kit instructions for the individual kits on our product page.
You can either plance an order by using our webshop or by contacting our sales representatives directly at order@navinci.se.
Visit our webshop to see the product list prices or contact us at order@navinci.se if you wish to obtain a personal quote.
Please contact us directly at contact@navinci.se or on our webpage at navinci.se/distributors/ to find out if we have a local distributor in your area.
Products are typically delivered within one week from ordering within the EU and within ten days from ordering for the rest of the world.